Abstract
The treatment of ventricular arrhythmias has undergone vibrant change in the last 40 years, evolving from a largely intellectual exercise to an evidence-based, guideline-supported set of patient care strategies. This progress have been fueled by basic and clinical science and by the initial application of randomized clinical trials to the study of electrophysiology. Along the way, several strongly held beliefs were reconsidered, most notably the use of programmed stimulation or serial Holter montoring to guide pharmacologic therapy for ventricular tachycardia. Although antiarrhythmic drugs are still considered useful in reducing the frequency of recurrent VT episodes, our loss of confidence in guided drug therapy led to the development of device, surgical ablation, and catheter ablation therapies, which form the mainstay of treatment today.
KeyWords:
A few hours before his death he told me … he did not feel any bodily ailments, and … without any sign of anything amiss, he passed away from this life.
… through failure of the artery that feeds the heart … which I found to be very parched and shrunk and withered.
– Leonardo DaVinci
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bayes de Luna A, Coumel P, Leclerq JF (1989) Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 117:151–159
Bigger JT Jr, Fleiss JL, Kleiger R et al (1984) The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69:250–258
Ruberman W, Weinblatt E, Goldberg JD et al (1981) Ventricular premature complexes and sudden death after myocardial infarction. Circulation 64:297–305
Lown B (1979) Sudden cardiac death – 1978. Circulation 60:1593–1599
The Beta Blocker Heart Attack Study Group (1981) The beta-blocker heart attack trial. JAMA 246:2073–2074
Echt DS, Liebson PR, Mitchell LB et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 324:781–788
Wellens HJ, Schuilenburg RM, Durrer D (1972) Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation 46:216–226
Josephson M (2008) Clinical cardiac electrophysiology: techniques and interpretations, 4th edn. Lippincott Williams & Wilkins, Philadelphia
Horowitz LN, Josephson ME, Farshidi A et al (1978) Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation 58:986–997
Mason JW, Winkle RA (1978) Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation 58:971–985
Waspe LE, Seinfeld D, Ferrick A et al (1985) Prediction of sudden death and spontaneous ventricular tachycardia in survivors of complicated myocardial infarction: value of the response to programmed stimulation using a maximum of three ventricular extrastimuli. J Am Coll Cardiol 5:1292–1301
Waller TJ, Kay HR, Spielman SR et al (1987) Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachycardia. J Am Coll Cardiol 10:83–89
Poll DS, Marchlinski FE, Buxton AE et al (1984) Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation 70:451–456
Investigators E (1989) The ESVEM trial. Electrophysiologic study versus electrocardiographic monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. Circulation 79:1354–1360
Wellens HJ, Bar FW, Farre J et al (1980) Initiation and termination of ventricular tachycardia by supraventricular stimuli. Incidence and electrophysiologic determinants as observed during programmed stimulation of the heart. Am J Cardiol 46:576–582
Roy D, Waxman HL, Buxton AE et al (1982) Termination of ventricular tachycardia: role of tachycardia cycle length. Am J Cardiol 50:1346–1350
Josephson ME, Horowitz LN, Farshidi A et al (1978) Recurrent sustained ventricular tachycardia. 2. Endocardial mapping. Circulation 57:440–447
Josephson ME, Horowitz LN, Spielman SR et al (1980) Comparison of endocardial catheter mapping with intraoperative mapping of ventricular tachycardia. Circulation 61:395–404
Cassidy DM, Vassallo JA, Miller JM et al (1986) Endocardial catheter mapping in patients in sinus rhythm: relationship to underlying heart disease and ventricular arrhythmias. Circulation 73:645–652
Kienzle MG, Miller J, Falcone RA et al (1984) Intraoperative endocardial mapping during sinus rhythm: relationship to site of origin of ventricular tachycardia. Circulation 70:957–965
Guiraudon G, Fontaine G, Frank R et al (1978) Encircling endocardial ventriculotomy: a new surgical treatment for life-threatening ventricular tachycardias resistant to medical treatment following myocardial infarction. Ann Thoracic Surg 26:438–444
Mirowski M, Mower MM, Reid PR et al (1982) The automatic implantable defibrillator. New modality for treatment of life-threatening ventricular arrhythmias. Pacing Clin Electrophysiol 5:384–401
AVID (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The antiarrhythmics versus implantable defibrillators (AVID) investigators. N Engl J Med 337:1576–1583
Moss AJ, Zareba W, Hall WJ (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 348:1882–1890
Buxton AE, Lee KL, DiCarlo L et al (2000) Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter unsustained tachycardia trial investigators. N Engl J Med 342:1937–1945
Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883
Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. 352:225–237
Kadish A, Quigg R, Schaechter A et al (2000) Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol 23:338–343
Strickberger SA, Hummel JD, Bartlett TG et al (2003) Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia AMIOVIRT. J Am Coll Cardiol 41:1707–1712
Tung R, Zimetbaum P, Josephson ME (2008) A critical appraisal of implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death. J Am Coll Cardiol 52:1111–1121
Almendral JM, Stamato NJ, Rosenthal ME et al (1986) Resetting response patterns during sustained ventricular tachycardia: relationship to the excitable gap. Circulation 74:722–730
Almendral JM, Gottlieb CD, Rosenthal ME et al (1988) Entrainment of ventricular tachycardia: explanation for surface electrocardiographic phenomena by analysis of electrograms recorded within the tachycardia circuit. Circulation 77:569–580
Morady F, Kadish AH, Rosenheck S et al (1991) Concealed entrainment as a guide for catheter ablation of ventricular tachycardia in patients with prior myocardial infarction. J Am Coll Cardiol 17:678–689
Stevenson W, Khan H, Sager P et al (1993) Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 88:1647–1670
Marchlinski FE, Callans DJ, Gottlieb CD et al (2000) Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 101:1288–1296
Arenal A, del Castillo S, Gonzalez-Torrecilla E et al (2004) Tachycardia related channel in the scar tissue in patients with sustained monomorphic ventricular tachycardias. Influence of the voltage scar definition. Circulation 110:2568–2574
Reddy VY, Reynolds MR, Neuzil P et al (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357:2657–2665
Horowitz LN, Josephson ME, Kastor JA (1980) Intracardiac electrophysiologic studies as a method for the optimization of drug therapy in chronic ventricular arrhythmia. Prog Cardiovasc Dis 23:81–98
Kastor JA, Horowitz LN, Harken AH et al (1981) Clinical electrophysiology of ventricular tachycardia. N Engl J Med 304:1004
Stevenson WG, Wilber DJ, Natale A, et al (2008) Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation 118:2773–2782
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Callans, D.J., Josephson, M.E. (2011). Management of Ventricular Arrhythmias: An Historical Perspective. In: Yan, GX., Kowey, P. (eds) Management of Cardiac Arrhythmias. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-161-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-60761-161-5_1
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-160-8
Online ISBN: 978-1-60761-161-5
eBook Packages: MedicineMedicine (R0)